α-Glucosidase-IN-22 |
| Catalog No.GC70181 |
α-Glucosidase-IN-22 (compuesto 7i) es un benzimidazol, un inhibidor efectivo de la α-glucosidasa, con una IC50 de 0.64 μM. Es una molécula activa contra la diabetes y tiene potencial para ser utilizada en investigaciones sobre diabetes tipo 2 (T2DM).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2870693-28-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for α-Glucosidase-IN-22
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for α-Glucosidase-IN-22
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *